+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Liver Model Market by Model Type, Cell Source, Application, End Users - Global Forecast to 2030- Product Image
Human Liver Model Market by Model Type, Cell Source, Application, End Users - Global Forecast to 2030- Product Image
Sale

Human Liver Model Market by Model Type, Cell Source, Application, End Users - Global Forecast to 2030

  • PDF Icon

    Report

  • 187 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904934
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The human liver model market is rapidly advancing, driven by increasing demand for predictive in vitro and digital platforms for drug development and toxicity assessment. As traditional testing methods face limitations, next-generation liver models present senior decision-makers a strategic opportunity to strengthen innovation pipelines and improve research outcomes.

Market Snapshot: Human Liver Model Market

The Human Liver Model Market grew from USD 1.55 billion in 2024 to USD 1.68 billion in 2025. This sector is expected to continue its upward trajectory, with a projected CAGR of 8.53%, reaching USD 2.54 billion by 2030. Growth is fueled by high demand for reliable preclinical models, swift advancements in tissue engineering, and enhanced regulatory pressures to reduce animal testing.

Scope & Segmentation

This report delivers comprehensive coverage of the human liver model market landscape. Segmentation is provided to allow detailed forecasting, technology adoption tracking, and strategic market positioning across regions, model types, cell origins, applications, and stakeholders.

  • Model Types: 2D Models, 3D Models, Ex Vivo Models, Hybrid Models, In Silico Models, Liver Organoids
  • Cell Sources: Immortalized Liver Cell Lines, Primary Human Hepatocytes, Stem Cell-Derived Models
  • Applications: Drug Discovery, Physiological Studies, Toxicology Studies, Education
  • End Users: Biotech Companies, Contract Research Organizations, Pharmaceutical Companies, Research Laboratories
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Technologies: Three-dimensional bioprinting, microfluidic organ-on-chip platforms, organoids from pluripotent stem cells, computational modeling with artificial intelligence, hybrid ex vivo and in silico models
  • Companies Profiled: Ascendance Bio, BioIVT LLC, Cellink Global by BICO Group AB, CN Bio Innovations Ltd., Corning Incorporated, Cyfuse Biomedical K.K., EISCO Scientific LLC, Emulate Inc., Hurel Corporation, InSphero AG, Kirkstall Ltd, MIMETAS B.V., NeurOmics, Inc., Organovo Holdings Inc., Pandorum Technologies Private Limited, PhoenixBio Co., Ltd., STEMCELL Technologies Inc.

Key Takeaways for Senior Decision-Makers

  • Next-generation liver models integrate biological fidelity and computational power, bridging gaps between preclinical evaluation and clinical outcomes.
  • Collaborative ecosystems, including consortia and open-source frameworks, support standardization and accelerate solution deployment across industry and academia.
  • Bioengineering advances enable scalable, modular liver models for improved drug screening and safety testing, reducing reliance on animal models.
  • Platform selection is increasingly influenced by desired research outcomes, such as mechanistic toxicology, high-throughput screening, or physiological investigations.
  • Emerging regional leaders are leveraging targeted funding and strategic partnerships to fast-track adoption, particularly in Asia-Pacific and Europe.
  • Companies prioritizing flexible technology platforms, cross-sector partnerships, and end-user training are best positioned to sustain growth.

Tariff Impact: Response to 2025 Regulatory Changes

The introduction of new US tariffs in 2025 has caused notable financial pressure on liver model supply chains. These measures affect specialized reagents, biomanufacturing equipment, and imported cell lines. Major suppliers have responded by increasing domestic manufacturing to reduce cross-border risk. Smaller players, lacking economies of scale, face more severe operational challenges, prompting a shift toward regional sourcing and in-house production. The industry is adapting through strategic vendor diversification, creation of supply reserves, and tighter collaboration with domestic contract research organizations, ensuring business continuity despite disruptions.

Methodology & Data Sources

This research applies both primary and secondary methods, including quantitative and qualitative interviews with key opinion leaders, reviews of peer-reviewed literature, industry databases, and patent registries. Data triangulation, thematic coding, and scenario mapping ensure accuracy and actionable insights. All findings are validated through internal reviews and peer assessment to maintain integrity.

Why This Report Matters

  • Enables executives to align investment and technology strategies with evolving market forces and unmet research needs.
  • Delivers an actionable framework for navigating segmentation dynamics, regulatory pressures, and regional opportunities in the human liver model market.
  • Supports competitive benchmarking and partnership evaluation, equipping decision-makers to mitigate risk and capture emerging value.

Conclusion

As modeling platforms and business models evolve, flexibility and evidence-driven strategy will define successful navigation of this market. Forward-looking leaders who act on these insights will unlock opportunities in drug development and life sciences innovation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Human Liver Model Market, by Model Type
8.1. Introduction
8.2. 2D Models
8.3. 3D Models
8.4. Ex Vivo Models
8.5. Hybrid Models
8.6. In Silico Models
8.7. Liver Organoids
9. Human Liver Model Market, by Cell Source
9.1. Introduction
9.2. Immortalized Liver Cell Lines
9.3. Primary Human Hepatocytes
9.4. Stem Cell-Derived Models
10. Human Liver Model Market, by Application
10.1. Introduction
10.2. Drug Discovery
10.3. Education
10.3.1. Physiological Studies
10.3.2. Toxicology Studies
11. Human Liver Model Market, by End Users
11.1. Introduction
11.2. Biotech Companies
11.3. Contract Research Organizations
11.4. Pharmaceutical Companies
11.5. Research Laboratories
12. Americas Human Liver Model Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Human Liver Model Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Human Liver Model Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Ascendance Bio
15.3.2. BioIVT LLC
15.3.3. Cellink Global by BICO Group AB
15.3.4. CN Bio Innovations Ltd.
15.3.5. Corning Incorporated
15.3.6. Cyfuse Biomedical K.K.
15.3.7. EISCO Scientific LLC
15.3.8. Emulate Inc.
15.3.9. Hurel Corporation
15.3.10. InSphero AG
15.3.11. Kirkstall Ltd
15.3.12. MIMETAS B.V.
15.3.13. NeurOmics, Inc.
15.3.14. Organovo Holdings Inc.
15.3.15. Pandorum Technologies Private Limited
15.3.16. PhoenixBio Co., Ltd.
15.3.17. STEMCELL Technologies Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. HUMAN LIVER MODEL MARKET MULTI-CURRENCY
FIGURE 2. HUMAN LIVER MODEL MARKET MULTI-LANGUAGE
FIGURE 3. HUMAN LIVER MODEL MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL HUMAN LIVER MODEL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. HUMAN LIVER MODEL MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. HUMAN LIVER MODEL MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. HUMAN LIVER MODEL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN LIVER MODEL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY 2D MODELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY 3D MODELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY EX VIVO MODELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY HYBRID MODELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY IN SILICO MODELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY LIVER ORGANOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY IMMORTALIZED LIVER CELL LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY PRIMARY HUMAN HEPATOCYTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY STEM CELL-DERIVED MODELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY PHYSIOLOGICAL STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY TOXICOLOGY STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN LIVER MODEL MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES HUMAN LIVER MODEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. CANADA HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 41. CANADA HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 42. CANADA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. CANADA HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 44. CANADA HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 45. MEXICO HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 47. MEXICO HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. MEXICO HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 49. MEXICO HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. UNITED KINGDOM HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 67. UNITED KINGDOM HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 68. UNITED KINGDOM HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. UNITED KINGDOM HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 70. UNITED KINGDOM HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 71. GERMANY HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 72. GERMANY HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 73. GERMANY HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. GERMANY HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 75. GERMANY HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 76. FRANCE HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 77. FRANCE HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 78. FRANCE HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. FRANCE HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 80. FRANCE HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. RUSSIA HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 85. RUSSIA HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 86. ITALY HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 87. ITALY HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 88. ITALY HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. ITALY HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 90. ITALY HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 91. SPAIN HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 92. SPAIN HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 93. SPAIN HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. SPAIN HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 95. SPAIN HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. UNITED ARAB EMIRATES HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 100. UNITED ARAB EMIRATES HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 101. SAUDI ARABIA HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 102. SAUDI ARABIA HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 103. SAUDI ARABIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. SAUDI ARABIA HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 105. SAUDI ARABIA HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 106. SOUTH AFRICA HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 107. SOUTH AFRICA HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 108. SOUTH AFRICA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. SOUTH AFRICA HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 110. SOUTH AFRICA HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 111. DENMARK HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 112. DENMARK HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 113. DENMARK HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. DENMARK HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 115. DENMARK HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 116. NETHERLANDS HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 117. NETHERLANDS HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 118. NETHERLANDS HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. NETHERLANDS HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 120. NETHERLANDS HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 121. QATAR HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 122. QATAR HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 123. QATAR HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. QATAR HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 125. QATAR HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 126. FINLAND HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 127. FINLAND HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 128. FINLAND HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. FINLAND HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 130. FINLAND HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 141. EGYPT HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 142. EGYPT HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 143. EGYPT HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. EGYPT HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 145. EGYPT HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 146. TURKEY HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 147. TURKEY HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 148. TURKEY HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. TURKEY HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 150. TURKEY HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 156. NORWAY HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 157. NORWAY HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 158. NORWAY HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. NORWAY HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 160. NORWAY HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 161. POLAND HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 162. POLAND HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 163. POLAND HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. POLAND HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 165. POLAND HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 166. SWITZERLAND HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 167. SWITZERLAND HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 168. SWITZERLAND HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SWITZERLAND HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 170. SWITZERLAND HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 176. ASIA-PACIFIC HUMAN LIVER MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 177. CHINA HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 178. CHINA HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 179. CHINA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. CHINA HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 181. CHINA HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 182. INDIA HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 183. INDIA HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 184. INDIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. INDIA HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 186. INDIA HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 187. JAPAN HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 188. JAPAN HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 189. JAPAN HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. JAPAN HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 191. JAPAN HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. AUSTRALIA HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 196. AUSTRALIA HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 204. INDONESIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. INDONESIA HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 206. INDONESIA HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 207. THAILAND HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 208. THAILAND HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 209. THAILAND HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. THAILAND HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 211. THAILAND HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 214. PHILIPPINES HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. PHILIPPINES HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 216. PHILIPPINES HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 221. MALAYSIA HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 223. SINGAPORE HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 224. SINGAPORE HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. SINGAPORE HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 226. SINGAPORE HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN HUMAN LIVER MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN HUMAN LIVER MODEL MARKET SIZE, BY CELL SOURCE, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN HUMAN LIVER MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. TAIWAN HUMAN LIVER MODEL MARKET SIZE, BY EDUCATION, 2018-2030 (USD MILLION)
TABLE 236. TAIWAN HUMAN LIVER MODEL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 237. HUMAN LIVER MODEL MARKET SHARE, BY KEY PLAYER, 2024
TABLE 238. HUMAN LIVER MODEL MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Human Liver Model market report include:
  • Ascendance Bio
  • BioIVT LLC
  • Cellink Global by BICO Group AB
  • CN Bio Innovations Ltd.
  • Corning Incorporated
  • Cyfuse Biomedical K.K.
  • EISCO Scientific LLC
  • Emulate Inc.
  • Hurel Corporation
  • InSphero AG
  • Kirkstall Ltd
  • MIMETAS B.V.
  • NeurOmics, Inc.
  • Organovo Holdings Inc.
  • Pandorum Technologies Private Limited
  • PhoenixBio Co., Ltd.
  • STEMCELL Technologies Inc.

Table Information

Report AttributeDetails
No. of Pages187
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.68 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.54 Billion
Compound Annual Growth Rate8.5%
Regions CoveredGlobal
No. of Companies Mentioned18

Related Topics

Related Reports

Human Liver Model Market Size, Share & Trends Analysis Report By Product (2D Models, 3D Models), By Application (ADME Studies, Toxicology Testing), By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Human Liver Model Market Size, Share & Trends Analysis Report By Product (2D Models, 3D Models), By Application (ADME Studies, Toxicology Testing), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Human Liver Model Market: Analysis by Product Type, Application, End-use, and Region - Size, Trends and Forecasts to 2030 - Product Image

Human Liver Model Market: Analysis by Product Type, Application, End-use, and Region - Size, Trends and Forecasts to 2030

  • Report
  • 148 Pages
  • Global
From
Human Liver Models - Global Strategic Business Report - Product Image

Human Liver Models - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Human Liver Model Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Human Liver Model Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Human Liver Models Market 2024-2028 - Product Image

Human Liver Models Market 2024-2028

  • Report
  • 133 Pages
  • Global
From

About the Human Liver Model Market

The Human Liver Model market is a subset of the Clinical Trials market, focused on the development of in vitro models of the human liver. These models are used to study the effects of drugs and other compounds on the liver, and to predict the safety and efficacy of drugs in humans. The models are typically composed of human liver cells, and can be used to study the metabolism, toxicity, and pharmacokinetics of drugs. The models are also used to study the effects of genetic and environmental factors on the liver. The Human Liver Model market is growing due to the increasing demand for in vitro models for drug development and safety testing. The models are also being used to study the effects of diseases on the liver, such as hepatitis and cirrhosis. Companies in the Human Liver Model market include InSphero, Hepregen, and Emulate. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.